145 related articles for article (PubMed ID: 32089412)
1. Protein expression profiles and prognostic value of E2F family members in clear cell renal cell carcinoma.
Kim YS; Jung J; Jeong H; Oh HE; Lee JH; Lee ES; Choi JW
Pathol Res Pract; 2020 Apr; 216(4):152880. PubMed ID: 32089412
[TBL] [Abstract][Full Text] [Related]
2. Divergent siblings: E2F2 and E2F4 but not E2F1 and E2F3 induce DNA synthesis in cardiomyocytes without activation of apoptosis.
Ebelt H; Hufnagel N; Neuhaus P; Neuhaus H; Gajawada P; Simm A; Müller-Werdan U; Werdan K; Braun T
Circ Res; 2005 Mar; 96(5):509-17. PubMed ID: 15718499
[TBL] [Abstract][Full Text] [Related]
3. [Interaction of E2F/Rb family members with factor binding to co-repressor element on B-myb and E2F1 promoters].
Nakajima Y
Kokubyo Gakkai Zasshi; 1998 Jun; 65(2):172-88. PubMed ID: 9711036
[TBL] [Abstract][Full Text] [Related]
4. Prognostic analysis of E2F transcription factors E2F1 and E2F3 in four independent pediatric neuroblastoma cohorts.
Wang H; Wang X; Xu L; Zhang J
BMC Pediatr; 2022 Jun; 22(1):376. PubMed ID: 35764946
[TBL] [Abstract][Full Text] [Related]
5. KLF6 Suppresses Metastasis of Clear Cell Renal Cell Carcinoma via Transcriptional Repression of E2F1.
Gao Y; Li H; Ma X; Fan Y; Ni D; Zhang Y; Huang Q; Liu K; Li X; Wang L; Gu L; Yao Y; Ai Q; Du Q; Song E; Zhang X
Cancer Res; 2017 Jan; 77(2):330-342. PubMed ID: 27780824
[TBL] [Abstract][Full Text] [Related]
6. Identification of the Expression and Clinical Significance of E2F Family in Clear Cell Renal Cell Carcinoma.
Chen R; Zhang Z; Hu B; Jiang M; Zheng P; Deng W; Fu B; Sun T
Int J Gen Med; 2022; 15():1193-1212. PubMed ID: 35153510
[TBL] [Abstract][Full Text] [Related]
7. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
Rabjerg M
Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
[TBL] [Abstract][Full Text] [Related]
8. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
Jones SJ; Dicker AJ; Dahler AL; Saunders NA
J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
[TBL] [Abstract][Full Text] [Related]
9. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
Halaban R; Cheng E; Smicun Y; Germino J
J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
[TBL] [Abstract][Full Text] [Related]
10. Prognostic values of
Manicum T; Ni F; Ye Y; Fan X; Chen BC
Biosci Rep; 2018 Dec; 38(6):. PubMed ID: 30487158
[TBL] [Abstract][Full Text] [Related]
11. The relationship between E2F family members and tumor growth in colorectal adenocarcinomas: A comparative immunohistochemical study of 100 cases.
Xanthoulis A; Kotsinas A; Tiniakos D; Fiska A; Tentes AA; Kyroudi A; Kittas C; Gorgoulis V
Appl Immunohistochem Mol Morphol; 2014 Jul; 22(6):471-7. PubMed ID: 22688350
[TBL] [Abstract][Full Text] [Related]
12. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
Araki K; Nakajima Y; Eto K; Ikeda MA
Oncogene; 2003 Oct; 22(48):7632-41. PubMed ID: 14576826
[TBL] [Abstract][Full Text] [Related]
13. E2F1 promotes proliferation and metastasis of clear cell renal cell carcinoma via activation of SREBP1-dependent fatty acid biosynthesis.
Shen D; Gao Y; Huang Q; Xuan Y; Yao Y; Gu L; Huang Y; Zhang Y; Li P; Fan Y; Tang L; Du S; Wu S; Wang H; Wang C; Gong H; Pang Y; Ma X; Wang B; Zhang X
Cancer Lett; 2021 Aug; 514():48-62. PubMed ID: 34019961
[TBL] [Abstract][Full Text] [Related]
14. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
[TBL] [Abstract][Full Text] [Related]
15. Expression and prognostic value of E2F activators in NSCLC and subtypes: a research based on bioinformatics analysis.
Gao Z; Shi R; Yuan K; Wang Y
Tumour Biol; 2016 Nov; 37(11):14979-14987. PubMed ID: 27655285
[TBL] [Abstract][Full Text] [Related]
16. Overexpression of E2F1 promotes tumor malignancy and correlates with TNM stages in clear cell renal cell carcinoma.
Ma X; Gao Y; Fan Y; Ni D; Zhang Y; Chen W; Zhang P; Song E; Huang Q; Ai Q; Li H; Wang B; Zheng T; Shi T; Zhang X
PLoS One; 2013; 8(9):e73436. PubMed ID: 24023875
[TBL] [Abstract][Full Text] [Related]
17. Proteomics identified nuclear N-myc downstream-regulated gene 1 as a prognostic tissue biomarker candidate in renal cell carcinoma.
Hosoya N; Sakumoto M; Nakamura Y; Narisawa T; Bilim V; Motoyama T; Tomita Y; Kondo T
Biochim Biophys Acta; 2013 Dec; 1834(12):2630-9. PubMed ID: 23999030
[TBL] [Abstract][Full Text] [Related]
18. High expression of Mucin13 associates with grimmer postoperative prognosis of patients with non-metastatic clear-cell renal cell carcinoma.
Xu Z; Liu Y; Yang Y; Wang J; Zhang G; Liu Z; Fu H; Wang Z; Liu H; Xu J
Oncotarget; 2017 Jan; 8(5):7548-7558. PubMed ID: 27911274
[TBL] [Abstract][Full Text] [Related]
19. NEIL3 promotes cell proliferation of ccRCC via the cyclin D1-Rb-E2F1 feedback loop regulation.
Zhang M; Jiang Y; Wang J; Yue Y; Liu W; Wang L; Li Y; Wang W; Cai H; Yang Z; Ma M; Lu S; Fan J
DNA Repair (Amst); 2024 Jan; 133():103604. PubMed ID: 37992567
[TBL] [Abstract][Full Text] [Related]
20. Novel lincRNA SLINKY is a prognostic biomarker in kidney cancer.
Gong X; Siprashvili Z; Eminaga O; Shen Z; Sato Y; Kume H; Homma Y; Ogawa S; Khavari PA; Pollack JR; Brooks JD
Oncotarget; 2017 Mar; 8(12):18657-18669. PubMed ID: 28423633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
